Related Experiment Videos
Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug
Evan Wood1, Thomas Kerr, Elisa Lloyd-Smith
1British Columbia Centre for Excellence in HIV/AIDS, St, Paul's Hospital; Vancouver, BC, Canada. ewood@cfenet.ubc.ca.
Harm Reduction Journal
|November 13, 2004
Summary
Vancouver
Area of Science:
- Public Health
- Epidemiology
- Sociology
Background:
- Injection drug users (IDUs) face epidemics of infectious diseases like HIV and HCV.
- Overdose and public drug use present significant public health and order challenges.
- Vancouver established a pilot medically supervised safer injecting facility (SIF) in 2003.
Purpose of the Study:
- To outline the methodology for evaluating the Vancouver SIF.
- To report preliminary observations on the SIF's impacts.
- To rigorously assess the SIF's benefits and potential harms.
Main Methods:
- Prospective cohort study of SIF users examining risk behavior, infection transmission, overdose, and health service use.
- Analysis of SIF process data.
- Surveys of local residents, qualitative interviews with stakeholders, and public order evaluations.
Main Results:
- Preliminary data indicate the SIF successfully attracts IDUs and reduces public drug use.
- Rigorous scientific evaluation is ongoing to quantify overall impacts.
- Long-term data collection is necessary to fully assess the SIF's consequences.
Conclusions:
- The SIF shows promise in mitigating public health issues associated with injection drug use.
- Comprehensive evaluation is crucial for understanding the full impact of supervised injecting facilities.
- Further research is needed to determine long-term benefits and drawbacks.